Impact of systemic venous congestion in heart failure (Q37921161)

25 August 2017

1 reference

title

Impact of systemic venous congestion in heart failure (English)

1 reference

25 August 2017

0 references

Matthias Dupont

1

1 reference

PubMed ID

21861070

25 August 2017

Wilfried Mullens

series ordinal

2

1 reference

PubMed ID

21861070

25 August 2017

W H Wilson Tang

series ordinal

3

1 reference

25 August 2017

1 December 2011

1 reference

Current heart failure reports

25 August 2017

1 reference

25 August 2017

8

1 reference

25 August 2017

4

1 reference

25 August 2017

233-241

1 reference

https://scigraph.springernature.com/pub.10.1007/s11897-011-0071-7

25 August 2017

0 references

cites work

2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

Readmission after hospitalization for congestive heart failure among Medicare beneficiaries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

Intrathoracic Impedance Monitoring in Patients With Heart Failure: Correlation With Fluid Status and Feasibility of Early Warning Preceding Hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

Hormones and hemodynamics in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

Neurohumoral pathways in heart failure with preserved systolic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

Congestion in chronic systolic heart failure is related to renal dysfunction and increased mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

Usefulness of Isosorbide Dinitrate and Hydralazine as add-on therapy in patients discharged for advanced decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

Combination of isosorbide dinitrate and hydralazine in blacks with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

The effect of cardiac resynchronization on morbidity and mortality in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

The mechanism of decrease in dynamic mitral regurgitation during heart failure treatment: importance of reduction in the regurgitant orifice size

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

Endothelial cell activation in patients with decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

Venous congestion and endothelial cell activation in acute decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

Renal function as a predictor of outcome in a broad spectrum of patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

Importance of venous congestion for worsening of renal function in advanced decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

Effect of right ventricular function and venous congestion on cardiorenal interactions during the treatment of decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

Prompt reduction in intra-abdominal pressure following large-volume mechanical fluid removal improves renal insufficiency in refractory decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

Ischemic hepatitis: clinical presentation and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

Telemonitoring in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

Relation of loop diuretic dose to mortality in advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: failure of furosemide to provide the same result

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

Continuous monitoring of intrathoracic impedance and right ventricular pressures in patients with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

Sodium nitroprusside for advanced low-output heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

Executive Summary: HFSA 2010 Comprehensive Heart Failure Practice Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0071-7

A METHOD FOR THE DETECTION AND QUANTIFICATION OF IMPAIRED SODIUM EXCRETION. RESULTS OF AN ORAL SODIUM TOLERANCE TEST IN NORMAL SUBJECTS AND IN PATIENTS WITH HEART DISEASE

21 January 2018

1 reference

12 December 2020

The limited reliability of physical signs for estimating hemodynamics in chronic heart failure

1 reference

12 December 2020

Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation

1 reference

12 December 2020

Anaemia in chronic heart failure is not only related to impaired renal perfusion and blunted erythropoietin production, but to fluid retention as well

1 reference

12 December 2020

The influence of venous pressure on the isolated mammalian kidney

1 reference

12 December 2020

Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)

1 reference

12 December 2020

10.1007/S11897-011-0071-7

Identifiers

DOI

1 reference

25 August 2017

1 reference

PubMed ID

21861070